Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: Effects of MK-801 and haloperidol pretreatment

Psychopharmacology

Volumn 126, Issue 3, 1996, Pages 191-198

  Tolliver, Bryan K ^a   Ho, Lauren B ^a   Reid, Malcolm S ^a   Berger, S Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Behavioral sensitization; Dopamine; Excitatory amino acids; Glutamate; Locomotor activity; NMDA antagonist; Novelty; Restraint stress; Stereotypy

Indexed keywords

DEXAMPHETAMINE; DIZOCILPINE; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; IMMOBILIZATION STRESS; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; REGULATORY MECHANISM; SENSITIZATION;

EID: 0029739587     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246448     Document Type: Article

References (41)

1. Antelman SM, Eichler AJ, Black CA, Kocan D (1980) Interchangeability of stress and amphetamine in sensitization. Science 207: 329-331
2. Cador M, Cole BJ, Koob GF, Stinus L, Le Moal M (1993) Central administration of corticotropin releasing factor induces long-term sensitization to d-amphetamine. Brain Res 606: 181-186
3. Carey RJ, Dai H, Krost M, Huston J (1995) The NMDA receptor and cocaine: evidence that MK-801 can induce behavioral sensitization effects. Pharmacol Biochem Behav 51[4]: 901-908
4. Carlsson M, Carlsson A (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75: 221-226
5. Costall B, Naylor RJ (1977) Mesolimbic and extrapyramidal sites for the mediation of stereotyped behavior patterns and hyperactivity by amphetamine and apomorphine in the rat. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants. Plenum Press, New York, pp 47-76
6. Deroche V, Piazza PV, Casolini P, Maccari S, Le Moal M, Simon H (1992a) Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion. Brain Res 598: 343-348
7. Deroche V, Piazza PV, Maccari S, Le Moal M, Simon H (1992b) Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Res 584: 309-313
8. Ellinwood EH, Sudilovsky A, Nelson LM (1973) Evolving behavior in the clinical and experimental (model) amphetamine psychosis. Am J Psychiatry 130: 1088-1093
9. Hamamura T, Fibiger HC (1993) Enhanced stress-induced dopamine release in the prefrontal cortex of amphetamine-sensitized rats. Eur J Pharmacol 237: 65-71
10. Herman J-P, Stinus L, Le Moal M (1984) Repeated stress increases locomotor response to amphetamine. Psychopharmacology 84: 431-435
11. Hooks MS, Kalivas PW (1994) Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity. J Pharmacol Exp Ther 269: 976-988
12. Ichikawa J, Meltzer HY (1992) The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo. Brain Res 574: 98-104
13. Kalivas PW, Alesdatter JE (1993) Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267: 486-495
14. Kalivas P, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16: 223-244
15. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45: 599-606
16. Karler R, Chaudhry IA, Calder LD, Turkanis SA (1990) Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res 537: 76-82
17. Kuribara H (1994) Early post-treatment with haloperidol retards induction of methamphetamine sensitization in mice. Eur J Pharmacol 256: 295-299
18. MacLennan AJ, Maier SF (1983) Coping and stress-induced potentiation of stimulant stereotypy in the rat. Science 219: 1091-1093
19. 2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacology 114: 239-242
20. Maurice T, Vignon J, Kamenka JM, Chicheportiche R (1991) Differential interaction on phencyclidine-like drugs with the dopamine uptake complex in vivo. J Neurochem 56: 553-559
21. Mele A, Cabib S, Oliverio A (1995) Effects of the NMDA antagonist, MK-801, on stress-induced alterations of dopamine-dependent behavior. Psychopharmacology 117: 313-317
22. Pauly JR, Robinson SF, Collins AC (1993) Chronic corticosterone administration enhances behavioral sensitization to amphetamine in mice. Brain Res 620: 195-202
23. Piazza PV, Deminiere J-M, Le Moal M, Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245: 1511-1513
24. Piazza PV, Deminiere J-M, Le Moal M, Simon H (1990) Stress-and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self- administration. Brain Res 514: 22-26
25. Piazza PV, Maccari S, Deminiere J-M, Le Moal M, Mormede P, Simon H (1991) Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA 88: 2088-2092
26. Post RM (1975) Cocaine psychoses: a continuum model. Am J Psychiatry 132: 225-231
27. Reimer AR, Martin-Iverson MT (1994) Nimodipine and haloperidol attenuate behavioral sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine. Psychopharmacology 113: 404-410
28. Robinson T, Becker J. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11: 157-198
29. Roth RH, Tam SY, Yang JX, Deutch A (1988) Stress and the mesocorticolimbic dopamine system. Ann NY Acad Sci 537: 138-147
30. Segal DS, Kuczenski R, Florin SM (1995) Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration? Behav Neurosci 109: 532-546
31. Snell LD, Yi SJ, Johnson KM (1988) Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release. Eur J Pharmacol 145: 223-226
32. Snyder SH (1973) Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. Am J Psychiatry 130: 61-67
33. Sorg BA, Kalivas PW (1991) Effects of cocaine and footshock on extracellular dopamine levels in the ventral striatum. Brain Res 559: 26-31
34. Stewart J, Druhan JP (1993) Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist MK-801. Psychopharmacology 110: 125-132
35. Thierry AM, Tassin JP, Blanc G, Glowinski J (1976) Selective activation of mesocortical dopamine system by stress. Nature 309: 350-352
36. Vezina P, Stewart J (1989) The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res 499: 108-120
37. Wedzony K, Czyrak A (1994) The role of corticosteroids in the acquisition of sensitization to loconiotor stimulant effects of MK-801. Brain Res 657: 351-356
38. Weiss SRB, Post RM, Pert A, Woodward R, Murman D (1989) Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression. Pharmacol Biochem Behav 34: 655-661
39. Wolf ME, Jeziorski M (1993) Coadministration of MK-801 with amphetamine, cocaine, or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 613: 291-294
40. Wolf ME, Khansa MR (1991) Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562: 164-168
41. Wolf ME, White FJ, Hu XT (1994) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 14: 1735-1745